235 related articles for article (PubMed ID: 15974896)
21. Kinetic analysis of the inhibition of human butyrylcholinesterase with cymserine.
Kamal MA; Al-Jafari AA; Yu QS; Greig NH
Biochim Biophys Acta; 2006 Feb; 1760(2):200-6. PubMed ID: 16309845
[TBL] [Abstract][Full Text] [Related]
22. Cholinesterases and the pathology of Alzheimer disease.
Geula C; Mesulam MM
Alzheimer Dis Assoc Disord; 1995; 9 Suppl 2():23-8. PubMed ID: 8534419
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
[TBL] [Abstract][Full Text] [Related]
24. Expression of cholinesterases in brain and non-brain tumours.
Vidal CJ
Chem Biol Interact; 2005 Dec; 157-158():227-32. PubMed ID: 16256970
[TBL] [Abstract][Full Text] [Related]
25. Butyrylcholinesterase-Mediated enhancement of the enzymatic activity of trypsin.
Darvesh S; Kumar R; Roberts S; Walsh R; Martin E
Cell Mol Neurobiol; 2001 Jun; 21(3):285-96. PubMed ID: 11569538
[TBL] [Abstract][Full Text] [Related]
26. Understanding the beneficial and detrimental effects of donepezil and rivastigmine to improve their therapeutic value.
Lane RM; Darreh-Shori T
J Alzheimers Dis; 2015; 44(4):1039-62. PubMed ID: 25408210
[TBL] [Abstract][Full Text] [Related]
27. Dual inhibition of acetylcholinesterase and butyrylcholinesterase enzymes by allicin.
Kumar S
Indian J Pharmacol; 2015; 47(4):444-6. PubMed ID: 26288480
[TBL] [Abstract][Full Text] [Related]
28. New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives.
Larik FA; Shah MS; Saeed A; Shah HS; Channar PA; Bolte M; Iqbal J
Int J Biol Macromol; 2018 Sep; 116():144-150. PubMed ID: 29729344
[TBL] [Abstract][Full Text] [Related]
29. Homocysteine thiolactone and human cholinesterases.
Darvesh S; Walsh R; Martin E
Cell Mol Neurobiol; 2007 Feb; 27(1):33-48. PubMed ID: 16955366
[TBL] [Abstract][Full Text] [Related]
30. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses.
Kuhl DE; Koeppe RA; Snyder SE; Minoshima S; Frey KA; Kilbourn MR
Ann Neurol; 2006 Jan; 59(1):13-20. PubMed ID: 16278840
[TBL] [Abstract][Full Text] [Related]
31. Changes in brain cholinesterases in senile dementia of Alzheimer type.
Perry EK; Perry RH; Blessed G; Tomlinson BE
Neuropathol Appl Neurobiol; 1978; 4(4):273-7. PubMed ID: 703927
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoids differentially control synthesis of acetylcholinesterase and butyrylcholinesterase in rat liver and brain.
Weber U; Brank M; Grubic Z
Chem Biol Interact; 1999 May; 119-120():341-7. PubMed ID: 10421470
[TBL] [Abstract][Full Text] [Related]
33. Advances in the treatment of Alzheimer's disease: benefits of dual cholinesterase inhibition.
Ballard CG
Eur Neurol; 2002; 47(1):64-70. PubMed ID: 11803198
[TBL] [Abstract][Full Text] [Related]
34. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
[TBL] [Abstract][Full Text] [Related]
36. Identification of hybrid cholinesterase forms consisting of acetyl- and butyrylcholinesterase subunits in human glioma.
García-Ayllón MS; Sáez-Valero J; Muñoz-Delgado E; Vidal CJ
Neuroscience; 2001; 107(2):199-208. PubMed ID: 11731094
[TBL] [Abstract][Full Text] [Related]
37. Rosmarinus officinalis L. leaf extract improves memory impairment and affects acetylcholinesterase and butyrylcholinesterase activities in rat brain.
Ozarowski M; Mikolajczak PL; Bogacz A; Gryszczynska A; Kujawska M; Jodynis-Liebert J; Piasecka A; Napieczynska H; Szulc M; Kujawski R; Bartkowiak-Wieczorek J; Cichocka J; Bobkiewicz-Kozlowska T; Czerny B; Mrozikiewicz PM
Fitoterapia; 2013 Dec; 91():261-271. PubMed ID: 24080468
[TBL] [Abstract][Full Text] [Related]
38. Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.
Hamodat H; Cash MK; Fisk JD; Darvesh S
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):571-583. PubMed ID: 28644906
[TBL] [Abstract][Full Text] [Related]
39. Gender-related differences in circadian rhythm of rat plasma acetyl- and butyrylcholinesterase: effects of sex hormone withdrawal.
Alves-Amaral G; Pires-Oliveira M; Andrade-Lopes AL; Chiavegatti T; Godinho RO
Chem Biol Interact; 2010 Jun; 186(1):9-15. PubMed ID: 20399201
[TBL] [Abstract][Full Text] [Related]
40. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
Wright CI; Geula C; Mesulam MM
Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]